![]() | |
Clinical data | |
---|---|
Trade names | Crestabolic, Cytobolin, Diandren, Madiol, Stenediol, Mestenediol |
Other names | Metandriol; Methylandrostenediol; Methyl-5-androstenediol; Methylandrostenediole; 17α-Methylandrost-5-ene-3β,17β-diol |
Routes of administration | By mouth |
Drug class | Androgen; Anabolic steroid |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.548 |
Chemical and physical data | |
Formula | C20H32O2 |
Molar mass | 304.474 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Methandriol (brand names Anabol, Crestabolic, Cytobolin, Diandren, Durabolic, Madiol, Mestenediol, Methabolic, Methydiol, Sterabolic, Stenediol), also known as methylandrostenediol, is an androgen and anabolic steroid (AAS) medication which was developed by Organon and is used in both oral and injectable (as methandriol dipropionate, methandriol propionate, or methandriol bisenanthoyl acetate) formulations.[2][3][4] It is an orally active 17α-alkylated AAS and a derivative of the endogenous androgen prohormone androstenediol.[2][3]
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search